Carnitine researcher recognized with award

- Last updated on GMT

Related tags: Clinical trial, Food and drug administration

Dr Stephen DeFelice
Dr Stephen DeFelice
Supplement industry pioneer Dr Stephen L. DeFelice has been honored with the 2013 Marconi Science award by UNICO, the largest Italian-American service organization at a recent meeting of the organization in Las Vegas.

Dr DeFelice, credited with coining the term “nutraceutical,” is an accomplished researcher, physician, author and advocate who did early research into the use of carnitine for a number of medical purposes and conducted the first clinical trial with it in the United States. He sponsored and undertook a series of laboratory studies which demonstrated that carnitine had multiple beneficial cardiovascular and other medical effects.

Through his further research and efforts he secured FDA approval for two clinical indications for the use of carnitine - Primary Carnitine Deficiency, a fatal disease in children and for renal dialysis patients. As a result many children's lives have been saved and the quality of life of dialysis patients improved. He is currently undertaking the initiation of clinical studies using carnitine on patients with ovarian cancer.

Dr DeFelice also founded the Foundation for Innovation in Medicine and has worked with Rep. Frank Pallone, D-NJ, on dietary supplement regulations.  Pallone, too, was recognized recently for his work in the field with an award from the Natural Products Association.

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars